Code
MOG-BASX-01BV
Test
Active-Compendium
81206, 81207
81479
Clinical
Oncology,Pathology
Bone Marrow: 2 mL EDTA tube. Sodium heparin acceptable.
Peripheral Blood: 5 mL EDTA tube. Sodium heparin acceptable.
Note: Test is RNA-based. Please select Extract & Hold - RNA if specimen hold service is desired.
Peripheral Blood: 5 mL EDTA tube. Sodium heparin acceptable.
Note: Test is RNA-based. Please select Extract & Hold - RNA if specimen hold service is desired.
Flag Active
True
Orderable Test Description
Real-time RT-PCR for quantitative detection of t(9;22) BCR-ABL1 fusion transcripts that result in major p210 (e13a2 and/or e14a2) or minor p190 (e1a2) fusion proteins with option to add p230 detection (micro or atypical variant). Analytical sensitivity is 0.002% for p210 and 0.005% for p190, depending on quality and quantity of the isolated RNA and absence of interfering substances. Log reduction score and percent abnormal are reported, and longitudinal data will appear as a NeoTRACK Result on the report. Testing is New York approved for p210 and p190 only. p230 testing may be ordered as a reflex if p210 and p190 are negative, or as a stand-alone test, BCR-ABL1 Non-Standard p230. For p230, results are reported as percent abnormal.
Orderable Turn Around Time
5 Days
Extra Note
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection. Please select Extract & Hold - RNA if specimen hold service is desired.
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"Polymerase Chain Reaction (PCR)": {"Fusions": ["BCR-ABL1"]}}
Keywords string
BCR, ABL1, Translocation, BCR ABL1, p210, p190, t(9;22) BCR-ABL1 Standard p210, p190
Title URL
bcr-abl1-standard-p210-p190